A recent study has shown that AKG is an effector molecule of p53-mediated tumor suppression, and its accumulation in p53-deficient tumors can partially recapitulate the p53 action linked with the remodeling of cancer cell metabolism through epigenetic modifications and alterations of gene expression [25]. The gene discussed is TP53; the disease is cancer.